nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—type 1 diabetes mellitus	0.675	1	CbGaD
Vemurafenib—Vasculitis—Ramipril—type 1 diabetes mellitus	0.00117	0.057	CcSEcCtD
Vemurafenib—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00104	0.0506	CcSEcCtD
Vemurafenib—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.000948	0.046	CcSEcCtD
Vemurafenib—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.000878	0.0426	CcSEcCtD
Vemurafenib—Arthritis—Ramipril—type 1 diabetes mellitus	0.000856	0.0416	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.000749	0.0364	CcSEcCtD
Vemurafenib—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.000712	0.0346	CcSEcCtD
Vemurafenib—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000657	0.0319	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000636	0.0309	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.000629	0.0305	CcSEcCtD
Vemurafenib—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000567	0.0275	CcSEcCtD
Vemurafenib—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000566	0.0275	CcSEcCtD
Vemurafenib—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.000544	0.0264	CcSEcCtD
Vemurafenib—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000519	0.0252	CcSEcCtD
Vemurafenib—Alopecia—Ramipril—type 1 diabetes mellitus	0.000509	0.0247	CcSEcCtD
Vemurafenib—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000501	0.0243	CcSEcCtD
Vemurafenib—Erythema—Ramipril—type 1 diabetes mellitus	0.000501	0.0243	CcSEcCtD
Vemurafenib—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000491	0.0238	CcSEcCtD
Vemurafenib—Cough—Ramipril—type 1 diabetes mellitus	0.000437	0.0212	CcSEcCtD
Vemurafenib—Myalgia—Ramipril—type 1 diabetes mellitus	0.000427	0.0207	CcSEcCtD
Vemurafenib—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000427	0.0207	CcSEcCtD
Vemurafenib—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000424	0.0206	CcSEcCtD
Vemurafenib—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000409	0.0199	CcSEcCtD
Vemurafenib—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000401	0.0195	CcSEcCtD
Vemurafenib—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000397	0.0193	CcSEcCtD
Vemurafenib—Hypotension—Ramipril—type 1 diabetes mellitus	0.000382	0.0186	CcSEcCtD
Vemurafenib—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000373	0.0181	CcSEcCtD
Vemurafenib—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000356	0.0173	CcSEcCtD
Vemurafenib—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000353	0.0171	CcSEcCtD
Vemurafenib—Fatigue—Ramipril—type 1 diabetes mellitus	0.000353	0.0171	CcSEcCtD
Vemurafenib—Constipation—Ramipril—type 1 diabetes mellitus	0.00035	0.017	CcSEcCtD
Vemurafenib—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000323	0.0157	CcSEcCtD
Vemurafenib—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000301	0.0146	CcSEcCtD
Vemurafenib—Asthenia—Ramipril—type 1 diabetes mellitus	0.000293	0.0142	CcSEcCtD
Vemurafenib—Pruritus—Ramipril—type 1 diabetes mellitus	0.000289	0.014	CcSEcCtD
Vemurafenib—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00028	0.0136	CcSEcCtD
Vemurafenib—Dizziness—Ramipril—type 1 diabetes mellitus	0.00027	0.0131	CcSEcCtD
Vemurafenib—Vomiting—Ramipril—type 1 diabetes mellitus	0.00026	0.0126	CcSEcCtD
Vemurafenib—Rash—Ramipril—type 1 diabetes mellitus	0.000258	0.0125	CcSEcCtD
Vemurafenib—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000258	0.0125	CcSEcCtD
Vemurafenib—Headache—Ramipril—type 1 diabetes mellitus	0.000256	0.0124	CcSEcCtD
Vemurafenib—Nausea—Ramipril—type 1 diabetes mellitus	0.000243	0.0118	CcSEcCtD
Vemurafenib—RAF1—Signaling by FGFR in disease—IL6—type 1 diabetes mellitus	7.63e-05	0.00025	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DPB1—type 1 diabetes mellitus	7.62e-05	0.00025	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	7.61e-05	0.00025	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—STAT3—type 1 diabetes mellitus	7.57e-05	0.000248	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR—IL6—type 1 diabetes mellitus	7.56e-05	0.000248	CbGpPWpGaD
Vemurafenib—BRAF—Signaling by NGF—IL6—type 1 diabetes mellitus	7.51e-05	0.000247	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-E—type 1 diabetes mellitus	7.5e-05	0.000246	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by EGFR in Cancer—IL6—type 1 diabetes mellitus	7.49e-05	0.000246	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HLA-DRB1—type 1 diabetes mellitus	7.46e-05	0.000245	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—IL6—type 1 diabetes mellitus	7.46e-05	0.000245	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GAL—type 1 diabetes mellitus	7.44e-05	0.000244	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—STAT3—type 1 diabetes mellitus	7.44e-05	0.000244	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS1—type 1 diabetes mellitus	7.42e-05	0.000244	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	7.41e-05	0.000243	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SST—type 1 diabetes mellitus	7.37e-05	0.000242	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ITPR3—type 1 diabetes mellitus	7.36e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL11—type 1 diabetes mellitus	7.36e-05	0.000242	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL20—type 1 diabetes mellitus	7.36e-05	0.000242	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HBA2—type 1 diabetes mellitus	7.35e-05	0.000241	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADRB1—type 1 diabetes mellitus	7.34e-05	0.000241	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IGF1—type 1 diabetes mellitus	7.29e-05	0.000239	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CTLA4—type 1 diabetes mellitus	7.23e-05	0.000237	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—VAV1—type 1 diabetes mellitus	7.19e-05	0.000236	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	7.18e-05	0.000236	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD80—type 1 diabetes mellitus	7.18e-05	0.000236	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	7.17e-05	0.000236	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PRKCQ—type 1 diabetes mellitus	6.95e-05	0.000228	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—HBA1—type 1 diabetes mellitus	6.93e-05	0.000227	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CHRM2—type 1 diabetes mellitus	6.92e-05	0.000227	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—G6PC2—type 1 diabetes mellitus	6.91e-05	0.000227	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ALB—type 1 diabetes mellitus	6.91e-05	0.000227	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ERBB3—type 1 diabetes mellitus	6.9e-05	0.000226	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD79A—type 1 diabetes mellitus	6.9e-05	0.000226	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD80—type 1 diabetes mellitus	6.89e-05	0.000226	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APOC3—type 1 diabetes mellitus	6.89e-05	0.000226	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TYK2—type 1 diabetes mellitus	6.86e-05	0.000225	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CCR5—type 1 diabetes mellitus	6.78e-05	0.000223	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PRKCQ—type 1 diabetes mellitus	6.77e-05	0.000222	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GSTT1—type 1 diabetes mellitus	6.76e-05	0.000222	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—EGFR—type 1 diabetes mellitus	6.76e-05	0.000222	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—type 1 diabetes mellitus	6.76e-05	0.000222	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—VAV1—type 1 diabetes mellitus	6.75e-05	0.000221	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS1—type 1 diabetes mellitus	6.67e-05	0.000219	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS1—type 1 diabetes mellitus	6.62e-05	0.000217	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HLA-A—type 1 diabetes mellitus	6.61e-05	0.000217	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NOS3—type 1 diabetes mellitus	6.61e-05	0.000217	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—VAV1—type 1 diabetes mellitus	6.57e-05	0.000216	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GCG—type 1 diabetes mellitus	6.57e-05	0.000216	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	6.53e-05	0.000214	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ITPR3—type 1 diabetes mellitus	6.48e-05	0.000213	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DQA1—type 1 diabetes mellitus	6.36e-05	0.000209	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	6.33e-05	0.000208	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PRKCQ—type 1 diabetes mellitus	6.25e-05	0.000205	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.23e-05	0.000205	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ITPR3—type 1 diabetes mellitus	6.21e-05	0.000204	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PRKCQ—type 1 diabetes mellitus	6.19e-05	0.000203	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—VAV1—type 1 diabetes mellitus	6.14e-05	0.000202	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL10—type 1 diabetes mellitus	6.13e-05	0.000201	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—EGFR—type 1 diabetes mellitus	6.12e-05	0.000201	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IGF2—type 1 diabetes mellitus	6.11e-05	0.000201	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—HBA1—type 1 diabetes mellitus	6.1e-05	0.0002	CbGpPWpGaD
Vemurafenib—RAF1—Disease—VAV1—type 1 diabetes mellitus	6.07e-05	0.000199	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	6.07e-05	0.000199	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—TYK2—type 1 diabetes mellitus	6.06e-05	0.000199	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APOC3—type 1 diabetes mellitus	6.06e-05	0.000199	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—VAV1—type 1 diabetes mellitus	6.02e-05	0.000197	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ABCC8—type 1 diabetes mellitus	5.99e-05	0.000197	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.98e-05	0.000196	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DQB1—type 1 diabetes mellitus	5.95e-05	0.000195	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GSTT1—type 1 diabetes mellitus	5.95e-05	0.000195	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.93e-05	0.000195	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	5.87e-05	0.000193	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	5.85e-05	0.000192	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SH2B3—type 1 diabetes mellitus	5.85e-05	0.000192	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IAPP—type 1 diabetes mellitus	5.81e-05	0.000191	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—APOC3—type 1 diabetes mellitus	5.81e-05	0.000191	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS2—type 1 diabetes mellitus	5.75e-05	0.000189	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD86—type 1 diabetes mellitus	5.73e-05	0.000188	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	5.71e-05	0.000187	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD40LG—type 1 diabetes mellitus	5.62e-05	0.000185	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—IL2—type 1 diabetes mellitus	5.6e-05	0.000184	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD80—type 1 diabetes mellitus	5.58e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCR5—type 1 diabetes mellitus	5.56e-05	0.000183	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IGF2—type 1 diabetes mellitus	5.56e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD8A—type 1 diabetes mellitus	5.56e-05	0.000182	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	5.48e-05	0.00018	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—CD4—type 1 diabetes mellitus	5.48e-05	0.00018	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GCG—type 1 diabetes mellitus	5.39e-05	0.000177	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CD86—type 1 diabetes mellitus	5.36e-05	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-B—type 1 diabetes mellitus	5.35e-05	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD86—type 1 diabetes mellitus	5.29e-05	0.000174	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—type 1 diabetes mellitus	5.29e-05	0.000174	CbGpPWpGaD
Vemurafenib—BRAF—Disease—INS—type 1 diabetes mellitus	5.27e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—CD4—type 1 diabetes mellitus	5.26e-05	0.000173	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD86—type 1 diabetes mellitus	5.25e-05	0.000172	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.22e-05	0.000171	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—type 1 diabetes mellitus	5.2e-05	0.000171	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ERBB3—type 1 diabetes mellitus	5.17e-05	0.00017	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2RA—type 1 diabetes mellitus	5.14e-05	0.000169	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	5.14e-05	0.000169	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SST—type 1 diabetes mellitus	5.1e-05	0.000167	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—E2F1—type 1 diabetes mellitus	5.08e-05	0.000167	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADRB1—type 1 diabetes mellitus	5.08e-05	0.000167	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2RA—type 1 diabetes mellitus	5.01e-05	0.000164	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-A—type 1 diabetes mellitus	4.95e-05	0.000163	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	4.95e-05	0.000162	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	4.83e-05	0.000159	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ERBB3—type 1 diabetes mellitus	4.83e-05	0.000159	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—STAT3—type 1 diabetes mellitus	4.81e-05	0.000158	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ERBB3—type 1 diabetes mellitus	4.77e-05	0.000157	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCR5—type 1 diabetes mellitus	4.75e-05	0.000156	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GCG—type 1 diabetes mellitus	4.74e-05	0.000156	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—KCNJ11—type 1 diabetes mellitus	4.74e-05	0.000155	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ERBB3—type 1 diabetes mellitus	4.73e-05	0.000155	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CRP—type 1 diabetes mellitus	4.73e-05	0.000155	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TYK2—type 1 diabetes mellitus	4.71e-05	0.000155	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—type 1 diabetes mellitus	4.7e-05	0.000154	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CCR5—type 1 diabetes mellitus	4.69e-05	0.000154	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2RA—type 1 diabetes mellitus	4.68e-05	0.000154	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CCR5—type 1 diabetes mellitus	4.65e-05	0.000153	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NOS3—type 1 diabetes mellitus	4.62e-05	0.000152	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HLA-A—type 1 diabetes mellitus	4.57e-05	0.00015	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CAT—type 1 diabetes mellitus	4.56e-05	0.00015	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GCG—type 1 diabetes mellitus	4.55e-05	0.000149	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HLA-A—type 1 diabetes mellitus	4.53e-05	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DRB1—type 1 diabetes mellitus	4.53e-05	0.000149	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS2—type 1 diabetes mellitus	4.42e-05	0.000145	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	4.38e-05	0.000144	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—EGFR—type 1 diabetes mellitus	4.37e-05	0.000143	CbGpPWpGaD
Vemurafenib—BRAF—Disease—CD4—type 1 diabetes mellitus	4.26e-05	0.00014	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—VAV1—type 1 diabetes mellitus	4.25e-05	0.00014	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL10—type 1 diabetes mellitus	4.24e-05	0.000139	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	4.19e-05	0.000138	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD80—type 1 diabetes mellitus	4.18e-05	0.000137	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—type 1 diabetes mellitus	4.16e-05	0.000137	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CAT—type 1 diabetes mellitus	4.01e-05	0.000132	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ITPR3—type 1 diabetes mellitus	4e-05	0.000131	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS2—type 1 diabetes mellitus	3.98e-05	0.000131	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	3.97e-05	0.00013	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS2—type 1 diabetes mellitus	3.94e-05	0.000129	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IGF1—type 1 diabetes mellitus	3.92e-05	0.000129	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	3.91e-05	0.000128	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CD80—type 1 diabetes mellitus	3.91e-05	0.000128	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—TYK2—type 1 diabetes mellitus	3.86e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD80—type 1 diabetes mellitus	3.86e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—EGFR—type 1 diabetes mellitus	3.86e-05	0.000127	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF2—type 1 diabetes mellitus	3.85e-05	0.000126	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD80—type 1 diabetes mellitus	3.83e-05	0.000126	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—HBA1—type 1 diabetes mellitus	3.76e-05	0.000124	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APOC3—type 1 diabetes mellitus	3.74e-05	0.000123	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	3.73e-05	0.000122	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CD86—type 1 diabetes mellitus	3.71e-05	0.000122	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—EGFR—type 1 diabetes mellitus	3.7e-05	0.000122	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—INS—type 1 diabetes mellitus	3.69e-05	0.000121	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GSTT1—type 1 diabetes mellitus	3.67e-05	0.000121	CbGpPWpGaD
Vemurafenib—RAF1—Disease—INS—type 1 diabetes mellitus	3.65e-05	0.00012	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—INS—type 1 diabetes mellitus	3.62e-05	0.000119	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IGF1—type 1 diabetes mellitus	3.57e-05	0.000117	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NOS3—type 1 diabetes mellitus	3.56e-05	0.000117	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TYK2—type 1 diabetes mellitus	3.53e-05	0.000116	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—E2F1—type 1 diabetes mellitus	3.52e-05	0.000115	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—type 1 diabetes mellitus	3.36e-05	0.00011	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	3.34e-05	0.00011	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	3.31e-05	0.000109	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IFNG—type 1 diabetes mellitus	3.31e-05	0.000109	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	3.3e-05	0.000108	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.3e-05	0.000108	CbGpPWpGaD
Vemurafenib—BRAF—Disease—STAT3—type 1 diabetes mellitus	3.3e-05	0.000108	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCR5—type 1 diabetes mellitus	3.29e-05	0.000108	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TYK2—type 1 diabetes mellitus	3.26e-05	0.000107	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	3.24e-05	0.000106	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.24e-05	0.000106	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	3.23e-05	0.000106	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TYK2—type 1 diabetes mellitus	3.23e-05	0.000106	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL2—type 1 diabetes mellitus	3.21e-05	0.000106	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NOS3—type 1 diabetes mellitus	3.2e-05	0.000105	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD4—type 1 diabetes mellitus	3.19e-05	0.000105	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NOS3—type 1 diabetes mellitus	3.17e-05	0.000104	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	3.11e-05	0.000102	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	3.09e-05	0.000101	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	3.03e-05	9.95e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—INS—type 1 diabetes mellitus	3.03e-05	9.94e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—IL2—type 1 diabetes mellitus	3.01e-05	9.9e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—EGFR—type 1 diabetes mellitus	3e-05	9.84e-05	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—type 1 diabetes mellitus	2.96e-05	9.73e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—type 1 diabetes mellitus	2.95e-05	9.68e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—CD4—type 1 diabetes mellitus	2.95e-05	9.68e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL2—type 1 diabetes mellitus	2.94e-05	9.64e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GCG—type 1 diabetes mellitus	2.93e-05	9.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—CD4—type 1 diabetes mellitus	2.92e-05	9.59e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	2.8e-05	9.18e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—type 1 diabetes mellitus	2.78e-05	9.11e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CASP3—type 1 diabetes mellitus	2.75e-05	9.02e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL2—type 1 diabetes mellitus	2.74e-05	9.01e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CD80—type 1 diabetes mellitus	2.7e-05	8.87e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—INS—type 1 diabetes mellitus	2.66e-05	8.75e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—NOS3—type 1 diabetes mellitus	2.66e-05	8.72e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	2.63e-05	8.64e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	2.62e-05	8.59e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	2.57e-05	8.43e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	2.56e-05	8.39e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—INS—type 1 diabetes mellitus	2.55e-05	8.39e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CAT—type 1 diabetes mellitus	2.48e-05	8.13e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—STAT3—type 1 diabetes mellitus	2.47e-05	8.11e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IGF1—type 1 diabetes mellitus	2.47e-05	8.11e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	2.46e-05	8.07e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—type 1 diabetes mellitus	2.44e-05	8.02e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	2.42e-05	7.93e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	2.37e-05	7.77e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—NOS3—type 1 diabetes mellitus	2.34e-05	7.67e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.31e-05	7.58e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—type 1 diabetes mellitus	2.3e-05	7.56e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TYK2—type 1 diabetes mellitus	2.28e-05	7.49e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—STAT3—type 1 diabetes mellitus	2.28e-05	7.49e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—STAT3—type 1 diabetes mellitus	2.26e-05	7.43e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGFR—type 1 diabetes mellitus	2.25e-05	7.37e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NOS3—type 1 diabetes mellitus	2.24e-05	7.35e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	2.16e-05	7.08e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.1e-05	6.89e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—EGFR—type 1 diabetes mellitus	2.07e-05	6.81e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—EGFR—type 1 diabetes mellitus	2.06e-05	6.75e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	2.05e-05	6.72e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	2.05e-05	6.71e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	2.03e-05	6.67e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	2.02e-05	6.63e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.98e-05	6.51e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CASP3—type 1 diabetes mellitus	1.9e-05	6.24e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL2—type 1 diabetes mellitus	1.9e-05	6.23e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—type 1 diabetes mellitus	1.89e-05	6.2e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	1.73e-05	5.69e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—type 1 diabetes mellitus	1.73e-05	5.67e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—INS—type 1 diabetes mellitus	1.64e-05	5.4e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—type 1 diabetes mellitus	1.61e-05	5.3e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—STAT3—type 1 diabetes mellitus	1.6e-05	5.25e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—type 1 diabetes mellitus	1.59e-05	5.23e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—type 1 diabetes mellitus	1.58e-05	5.19e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.58e-05	5.19e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—EGFR—type 1 diabetes mellitus	1.45e-05	4.77e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—NOS3—type 1 diabetes mellitus	1.44e-05	4.73e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	1.36e-05	4.46e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	1.34e-05	4.39e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	1.24e-05	4.09e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	1.19e-05	3.91e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	1.15e-05	3.78e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—type 1 diabetes mellitus	1.12e-05	3.66e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	1.05e-05	3.46e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	1.01e-05	3.31e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	8.88e-06	2.91e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	8.14e-06	2.67e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	7.78e-06	2.56e-05	CbGpPWpGaD
